01 March 1996
Assessment of treadmill exercise test (TET) in patients with end-stage renal disease on maintainance dialysis
Magdalena Wierzbicka, Marek Maciejewski, Ewa Rutkowska, Dariusz StryjewskiMed Sci Monit 1996; 2(2): CR196-202 :: ID: 499567
Abstract
Cardiovascular disorders are the most common cause of morbidity and mortality in patients undergoing dialysis due to end-stage renal diseases accounting for approximately 50% of deaths in haemodialysed patients. The aim of our study was to evaluate the usefullness of the treadmill exercise test (TET) in detecting ischaemic heart disease (IHD) in haemodialyzed patients. Several variables were compared between the haemodialyzed patients with positive (TET ppts) and negative (TET npts) results of treadmill exercise test. Thirty seven patients (mean age 42 yrs) on maintenance haemodialysis (mean duration 29 months) were studied and 24.3% of them showed positive TET results. The TET-positive patients were significantly older with a poorer left ventricular diastolic performance (lower VmaxE, lower deceleration E) and considerably higher lipid index (triglycerides x cholesterol/HDL-chol) in comparison to TET-negative patients. We assume that these additional observations are associated with a higher ischaemic heart disease (IDH) risk in the haemodialyzed patients and seem to be helpful in selecting patients for coronarography. Evaluation of exercise tolerance in the haemodialyzed patients might also be an important indication in this invasive procedure. We believe that coronarography might be particularly indicated in the TET-positive patients on small workload ( < 5 MET) and also in those in whom adequate evaluation of the coronary reserve appears to be impossible since clinical criteria to cease the test have occured before the submaximal pulse can be reached.
Keywords: end-stage renal disease, haemodialysis, Coronary Artery Disease, lipid index, left ventricular diastolic function, treadmill exercise test
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952